All In Biotech

Free tool

FAERS Monitor: Risperdal

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021444 or its brand name (Risperdal, Risperidone). Reports on generic versions are filed under their own applications.

Reports

121,690

Serious

83,506

69% of reports

Hospitalization

38,163

Death reported

9,509

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • gynaecomastia24,513
  • off label use12,041
  • abnormal weight gain9,418
  • weight increased8,955
  • drug ineffective7,407
  • product use in unapproved indication5,949
  • emotional disorder5,930
  • injury4,624
  • drug interaction4,510
  • hyperprolactinaemia4,431
  • somnolence4,366
  • galactorrhoea3,713
  • obesity3,706
  • emotional distress3,524
  • extrapyramidal disorder3,385

Reports by year received

View as table
YearReports
20042,082
20052,052
20062,349
20072,212
20082,285
20093,901
20103,696
20113,714
20123,766
20133,060
20144,165
201512,683
201613,514
201713,077
20186,719
20197,609
20206,051
20214,894
20225,336
20234,928
20245,303
20254,852
20263,441

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,932,469 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
gynaecomastiaSignal24,513653.2635.93,332,238
abnormal weight gainSignal9,418549.7527.61,230,031
hyperprolactinaemiaSignal4,431370.4351.6517,700
galactorrhoeaSignal3,713235.1223.8365,693
obesitySignal3,70652.150.2142,601
emotional disorderSignal5,93040.939.8186,826
extrapyramidal disorderSignal3,38527.126.273,614
injurySignal4,62412.111.744,116
weight increasedSignal8,9557.27.046,026
emotional distressSignal3,5245.25.011,510
drug interactionSignal4,5105.04.914,243
product use in unapproved indicationSignal5,9494.24.114,467
somnolenceSignal4,3663.83.78,929
off label useSignal12,0412.42.410,077
drug ineffective7,4071.00.97

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.